Collegium Pharmaceutical (COLL) Restructuring Costs (2021 - 2025)

Collegium Pharmaceutical has reported Restructuring Costs for 3 years, with the latest figure at $10.9 million in Q3 2025.

• On a quarterly basis, Restructuring Costs rose 39.88% year-over-year to $10.9 million in Q3 2025; TTM through Sep 2025 was $43.5 million, a 50.89% increase from a year earlier, with the FY2024 full-year figure at $33.7 million, up 4.27% from the prior year.
• Restructuring Costs was $10.9 million for Q3 2025 at Collegium Pharmaceutical, up from $9.8 million in the prior quarter.
• The five-year high for Restructuring Costs was $13.3 million in Q1 2025, with the low at $4.6 million in Q4 2021.
• Average Restructuring Costs over 3 years is $9.0 million, with a median of $9.0 million recorded in 2024.
• The largest YoY upside for Restructuring Costs was 54.11% in 2025 against a maximum downside of 25.49% in 2025.
• Over 3 years, Restructuring Costs stood at $4.6 million in 2021, then soared by 106.92% to $9.5 million in 2024, then grew by 15.12% to $10.9 million in 2025.
• The last three Restructuring Costs figures came in at $10.9 million (Q3 2025), $9.8 million (Q2 2025), and $13.3 million (Q1 2025), per Business Quant data.